Antegenes is a biotechnology and healthcare company developing and implementing innovative genetic tests based on polygenic risk score technology to enable personalized prevention of common cancers.
Location: Estonia, Tartu
Employees: 11-50
Total raised: $2.93M
Founded date: 2018
Funding Rounds 2
| Date | Series | Amount | Investors |
| 02.08.2022 | - | $2.35M | - |
| 10.11.2021 | - | $577.46K | - |
Mentions in press and media 8
| Date | Title | Description |
| 27.09.2023 | EIT Health Awards 12 Elder Care Start-ups up to €50K | We are proud to announce the latest Healthy Longevity Catalyst Awardees. These awards are part of the Healthy Longevity Global Competition, which champions ground-breaking innovations focused on enhancing health and vitality in later life. ... |
| 28.07.2023 | 20 scale-ups selected for EIT Health Bridgehead 2023 | We are delighted to announce that we have selected twenty healthcare scale-ups to receive customised assistance to expand their businesses internationally through our Bridgehead programme in 2023. Our selected scale-ups represent a diverse ... |
| 31.08.2022 | Estonian startups that raised funding in August and are hiring right now | Estonia, a relatively small country, has significantly impacted the startup world thanks to its innovation and enthusiasm. It is a top startup ecosystem because of its supportive government policies, strong digital infrastructure, and high-... |
| 08.08.2022 | Estonian healthtech start-up Antegenes raises €2.3M | EIT Health-supported start-up, Antegenes, has raised €2.3 million in funding to bring its innovative genetic tests for personalised cancer prevention into broader use in healthcare, scale the team and expand to new foreign markets. Funding ... |
| 02.08.2022 | Estonian healthtech startup Antegenes secures €2.3 million to advance personalised cancer prevention | Healthtech startup Antegenes are pioneering a personalised approach to cancer prevention. The innovative company has now raised a total of €2.3 million and is ready to bring its tests to new markets across Europe. Cancer is one of the most ... |
| 08.02.2022 | Estonian health tech Antegenes gets €2.3 million shot to boost genetic tests for cancer prevention | Facilitating genetic tests for personalised cancer prevention, Estonian health technology company Antegenes has raised €2.3 million in funding. The investments will help bring personalised cancer prevention into wider use, including in new ... |
| 10.11.2021 | Estonian startup Antegenes raises €500k and expands to UK market to offer personalised cancer prevention methods | Founded in 2018, Estonian health tech company, Antegenes, has just raised €500k and signed a long-term strategic partnership agreement with UK-based healthcare company Everything Genetic Ltd. The fresh funding and new partnership will be us... |
| 01.07.2021 | Latvian startup Longenesis among the winners of the Fair Health Data Challenge | The Fair Health Data Challenge has announced the top three companies that exemplify fair digital health and well-being services and organisations. Latvian startup Longenesis is one of the winning enterprises whose solution will be presented... |